1. Li CL, Liu B, Wang ZY, Xie F, Qiao W, Cheng J, Kuang JY, Wang Y, Zhang MX*, Liu DS*. Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3.J Mol Cell Cardiol. 2020 Jan 23;139:98-112
2. Li P, Wang Y, Liu X, Liu B, Wang ZY, Xie F, Qiao W, Liang ES, Lu QH, Zhang MX*. Correction: Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via Stat1/Runx2 axis.Cell Death Dis. 2020 Feb 6;11(2):97.
3. Zhang JN, Ma Y, Wei XY, Liu KY, Wang H, Han H, Cui Y, Zhang MX, Qin WD*. Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway.Mediators Inflamm. 2019 Dec 31;2019:3013716.
4. Zhu TT, Zhang WF, Yin YL, Liu YH, Song P, Xu J, Zhang MX*, Li P*. MicroRNA‐140‐5p targeting tumor necrosis factor‐α prevents pulmonary arterial hypertension.J Cell Physiol. 2019 Jun;234(6):9535-9550.
5. hao T, Chen H, Xu F, Wang J, Liu Y, Xing X, Guo L, Zhang M, Lu Q*. Liraglutide alleviates cardiac fibrosis through inhibiting P4hα-1 expression in STZ-induced diabetic cardiomyopathy.Acta Biochim Biophys Sin (Shanghai). 2019 Mar 1;51(3):293-300.
6. Zhu TT, Sun RL, Yin YL, Quan JP, Song P, Xu J, Zhang MX*, Li P*. Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells.Pflugers Arch. 2019 Feb;471(2):347-355.
7. Liang ES, Bai WW, Wang H, Zhang JN, Zhang F, Ma Y, Jiang F, Yin M, Zhang MX, Chen XM*, Qin WD*. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.Hypertension. 2018 Nov;72(5):1189-1199.
8. Wang Q, Zhao T, Zhang W, Yu W, Liu B, Wang Z, Qiao W, Lu Q, Wang A, Zhang M*. Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction.Front Pharmacol. 2018 Aug 15;9:882.
9. Liu X, Mujahid H, Rong B, Lu QH, Zhang W, Li P, Li N, Liang ES, Wang Q, Tang DQ, Li NL, Ji XP, Chen YG, Zhao YX*, Zhang MX*. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy.J Cell Mol Med. 2018 Feb;22(2):808-822.
10. Lyu ZK, Li CL, Jin Y, Liu YZ, Zhang X, Zhang F, Ning LN, Liang ES, Ma M, Gao W, Zhang MX, Liu DS*. Paeonol exerts potential activities to inhibit the growth, migration and invasion of human gastric cancer BGC823 cells via downregulating MMP‑2 and MMP‑9.Mol Med Rep. 2017 Nov;16(5):7513-7519.
11. Wei SJ, Cheng L, Liang ES, Wang Q, Zhou SN, Xu H, Hui LH, Ge ZM*, Zhang MX*. Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.Clin Exp Pharmacol Physiol. 2017 Jan;44(1):114-122.
12. Liu X, Song X, Lu J, Chen X, Liang E, Liu X, Zhang M, Zhang Y, Du Z, Zhao Y*. Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice.Oncotarget. 2016 Sep 20;7(38):61703-61715.
13. Xu DL, Tian HL, Cai WL, Zheng J, Gao M, Zhang MX, Zheng ZT*, Lu QH*. Novel 6-bp deletion in MEF2A linked to premature coronary artery disease in a large Chinese family.Mol Med Rep. 2016 Jul;14(1):649-54.
14. Qin WD*, Liu GL, Wang J, Wang H, Zhang JN, Zhang F, Ma Y, Ji XY, Li C, Zhang MX*. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.Oncotarget. 2016 Jun 14;7(24):35618-35631.
15. Chen XY, Lv RJ, Zhang W, Yan YG, Li P, Dong WQ, Liu X, Liang ES, Tian HL, Lu QH*, Zhang MX*. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.Oncotarget. 2016 May 24;7(21):31053-66.
16. Qin WD, Zhang F, Qin XJ, Wang J, Meng X, Wang H, Guo HP, Wu QZ, Wu DW, Zhang MX*. Notch1 inhibition reduces low shear stress-induced plaque formation.Int J Biochem Cell Biol. 2016 Mar;72:63-72.
17. Dong WQ, Chao M, Lu QH, Chai WL, Zhang W, Chen XY, Liang ES, Wang LB, Tian HL, Chen YG*, Zhang MX*. Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy.Oncotarget. 2016 Jan 5;7(1):66-80.
18. Zhang GH, Chao M, Hui LH, Xu DL, Cai WL, Zheng J, Gao M, Zhang MX, Wang J*, Lu QH*. Poly(ADP-ribose)polymerase 1 inhibition protects against age-dependent endothelial dysfunction.Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1266-74.
19. Qiao W, Zhang W, Shao S, Gai Y, Zhang M. Effect and mechanism of poly (ADP-ribose) polymerase-1 in aldosterone-induced apoptosis.Mol Med Rep. 2015 Aug;12(2):1631-8.
20. Wu F, Song H, Zhang Y, Zhang Y, Mu Q, Jiang M, Wang F, Zhang W, Li L, Li H, WangY, Zhang M, Li S, Yang L, Meng Y, Tang D. Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway.PLoS One. 2015 Aug 4;10(8):e0134662.
21. Hao PP, Jiang F, Chen YG, Yang J, Zhang K, Zhang MX, Zhang C, Zhao YX,ZhangY. Evidence for traditional Chinese medication to treat cardiovascular disease.Nat Rev Cardiol. 2015 Jun;12(6):374.
22. Hao PP, Yang JM, Zhang MX, Zhang K, Chen YG, Zhang C, Zhang Y.Angiotensin-(1-7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy.Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1007-19.
23. Hao PP, Jiang F, Chen YG, Yang J, Zhang K, Zhang MX, Zhang C, Zhao YX, Zhang Y. Traditional Chinese medication for cardiovascular disease.Nat Rev Cardiol. 2015 Jun;12(6):318. doi: 10.1038/nrcardio.2015.60. Epub 2015 Apr 2. No abstract available.
24. Hao P, Yang J, Liu Y, Zhang M, Zhang K, Gao F, Chen Y, Zhang C, Zhang Y.Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy. Sci Rep. 2015 Mar 5;5:8794.
25. Qin WD, Mi SH, Li C, Wang GX, Zhang JN, Wang H, Zhang F, Ma Y, Wu DW, Zhang M. Low shear stress induced HMGB1 translocation and release via PECAM-1/PARP-1 pathway to induce inflammation response.PLoS One. 2015 Mar 20;10(3):e0120586.
26. Yan F, Zhang GH, Feng M, Zhang W, Zhang JN, Dong WQ, Zhang C, Zhang Y, Chen L, Zhang MX. Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.Mol Med. 2015 Feb 10;21:15-25.
27. Hao PP, Jiang F, Chen YG, Yang J, Zhang K, Zhang MX, Zhang C, Zhao YX, Zhang Y. Traditional Chinese medication for cardiovascular disease.Nat Rev Cardiol. 2015 Feb;12(2):115-22. doi: 10.1038/nrcardio.2014.177. Epub 2014 Nov 11.
28. Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, Wang Z, Zhang M, Li S, Yang L, Wang XL, Cui T, Tang D. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis.PLoS One. 2014 Oct 22;9(10):e110273.
29. Wang WK, Lu QH, Zhang JN, Wang B, Liu XJ, An FS, Qin WD, Chen XY, Dong WQ, Zhang C, Zhang Y, Zhang MX.HMGB1 mediates hyperglycaemi a-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway.J Cell Mol Med. 2014 Nov;18(11):2311-20. doi: 10.1111/jcmm.12399. Epub 2014 Sep 11.
30. Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, Zhang M, Zhang Y, An F. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.PLoS One. 2014 Aug 19;9(8):e104771.
31. Luo B, Li B, Wang W, Liu X, Liu X, Xia Y, Zhang C, Zhang Y, Zhang M, An F.Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.Cardiovasc Drugs Ther. 2014 Feb;28(1):33-43.
32. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L, Zhang M, Wang X, Cui T, Yang LJ, Tang D. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling.Diabetes. 2014 Feb;63(2):514-25.
33. Hao PP, Shang R, Liu YP, Hou GH, Zhang MX, Zhang C, Chen YG, Zhang Y.Cardiogenic shock from acute ST-segment elevation myocardial infarction induced by severe multivessel coronary vasospasm. Eur Heart J. 2014 Jan;35(3).
34. Wang WK, Wang B, Lu QH, Zhang W, Qin WD, Liu XJ, Liu XQ, An FS, Zhang Y*, Zhang MX*. Inhibition of high-mobility group box 1 improves myocardial fibrosis and dysfunction in diabetic cardiomyopathy. Int J Cardiol. 2014 Jan 21.
35. Qiao W, Chen L, Zhang M. MicroRNA-205 regulates the calcification and osteoblastic differentiation of vascular smooth muscle cells.Cell Physiol Biochem. 2014;33(6):1945-53.
36. Wang XP, Chen W, Li XQ, Wang WK, Yan F, Dong WQ, Zhang Y*, Zhang MX*.Arginase I enhances atherosclerotic plaque stabilization by inhibiting inflammation and promoting smooth muscle cell proliferation. European Heart Journal. 2013 SEP 1.
37. Yang JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, Hao PP, Li JJ, Wang XP, Zhang K, Gao F, Zhao XQ, Zhang MX, Zhang Y, Zhang C. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1978-85.
38. Li B, Dong Z, Liu H, Xia YF, Liu XM, Luo BB, Wang WK, Li B, Gao F, Zhang C, Zhang MX, Zhang Y, An FS. Serum amyloid A stimulates Lipoprotein associated phospholipase A2 expression in vitro and in vivo. Atherosclerosis. 2013 Jun;228(2):370-9.
39. Hao PP, Chen YG, Liu YP, Zhang MX, Yang JM, Gao F, Zhang Y, Zhang C. Association of plasma angiotensin-(1-7) level and left ventricular function in patients with type 2 diabetes mellitus. PLoS One. 2013 May 14;8(5)
40. Hao PP, Liu YP, Hou GH, Zhang MX, Chen YG, Zhang Y, Zhang C. Usefulness of angiotensin-(1-7) to predict myocardial salvage after percutaneous coronary intervention in patients with acute myocardial infarction. Int J Cardiol. 2013 Mar 5.
41. Qin WD, Wei SJ, Wang XP, Wang J, Wang WK, Liu F, Gong L, Yan F, Zhang Y, Zhang MX*. Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation. Biochim Biophys Acta. 2013 Jan;1833(1):59-68.
42. Wei SJ, Xing JH, Wang BL, Xue L, Wang JL, Li R, Qin WD, Wang J, Wang XP, Zhang MX*, Chen YG*. Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity. Biochim Biophys Acta. 2012 Nov 13.
43. Wang F, Zhao XQ, Liu JN, Wang ZH, Wang XL, Hou XY, Liu R, Gao F, Zhang MX, Zhang Y, Bu PL. Antagonist of microRNA-21 improves balloon injury-induced rat iliac artery remodeling by regulating proliferation and apoptosis of adventitial fibroblasts and myofibroblasts J Cell Biochem. 2012 Sep;113(9):2989-3001.
44. Wang XP, Chen YG, Qin WD, Zhang W, Wei SJ, Wang J, Liu FQ, Gong L, An FS, Zhang Y, Chen ZY*, Zhang MX*. Arginase I attenuates inflammatorycytokine secretion induced by lipopolysaccharide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1853-60.
45. Gong L, Liu FQ, Wang Y, Hou XG, Zhang W, Qin WD, Zhang Y, Chen L*, Zhang MX*. Poly (ADP-ribose) transferase/polymerase-1-deficient mice resistant to ge-dependent decrease in β-cell proliferation. Mol Med. 2012 Jul 18;18:816-24.
46. Wu Y, Wang Y, An C, Dong Z, Liu H, Zhang Y, Zhang MX*, An F*. Effects of rosuvastatin and atorvastatin on renal function: meta-analysis. Circ J. 2012;76(5):1259-66.
47. Liu YP#, Hao PP#, Zhang MX#, Zhang C, Gao F, Zhang Y, Chen YG. Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: an updated meta-analysis. Thromb Res. 2011 Dec;128(6):593-4.
48. Wang J, An FS, Zhang W, Gong L, Wei SJ, Qin WD, Wang XP, Zhao YX, Zhang Y, Zhang C*, Zhang MX*. Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice. Mol Med. 2011 Sep-Oct;17(9-10):990-9.
49. Dong Z, Wu T, Qin W, An C, Wang Z, Zhang M , Zhang Y, Zhang C, An F. Serum Amyloid A Directly Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice. Mol Med. 2011 Sep 21.
50. Dong Z, An F, Wu T, Zhang C, Zhang MX, Zhang Y, An G, An F. PTX3, a key component of innate immunity, is induced by SAA via FPRL1-mediated signaling in HAECs. J Cell Biochem. 2011 Aug;112(8):2097-105.
51. Liu FQ, Zhang XL, Gong L, Wang XP, Wang J, Hou XG, Sun Y, Qin WD, Wei SJ, Zhang Y, Chen L*, Zhang MX*. Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway. Mol Cell Endocrinol. 2011 Jun 6;339(1-2):25-33.
52. Gong L, Liu FQ, Wang J, Wang XP, Hou XG, Sun Y, Qin WD, Wei SJ, Zhang Y, Chen L*, Zhang MX*. Hyperglycemia induces apoptosis of pancreatic islet endothelial cells via reactive nitrogen species-mediated Jun N-terminal kinase activation. Biochim Biophys Acta. 2011 Jun;1813(6):1211-9
53. Liu CX, Hu Q, Wang Y, Zhang W, Ma ZY, Feng JB, Wang R, Wang XP, Dong B, Gao F, Zhang MX*, Zhang Y*.Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol Med. 2011; 17: 59-69.
54. Hao PP#, Zhang MX#, Li RJ, Yang JM, Wang JL, Chen YG, Zhang Y. Clopidogrel 150 mg/day Versus 75 mg/day in Patients Undergoing Percutaneous Coronary Intervention: a Meta-analysis. J Thromb Haemost. 2011; 21.
55. Zhang X#, Pei F#, Zhang MX#, Yan C, Huang M, Wang T, Han Y. Interleukin-17A Gene variants and risk of coronary artery disease: a large angiography-based study. Clin Chim Acta; 2011; 30; 412(3-4): 327-31
56. Wang T#, Zhang MX#, Han Y, Zhang X, Yan C, Liang Z, Sun Y, Kang J. Lack of association between cellular repressor of E1A-stimulated genes (GREG) polymorphisms and coronary artery disease in the Han population of North China. Clin Chim Acta; 2011; 30; 412(3-4): 249-52.
57. Zhao XQ, Zhang MW, Wang F, Zhao YX, Li JJ, Wang XP, Bu PL, Yang JM, Liu XL, Zhang MX, Gao F, Zhang C, Zhang Y. CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res. 2011 52(5):923-33.
58. Zhang X#, Pei F#, Zhang MX#, Yan C, Huang M, Wang T, Han Y. Interleukin-17 A gene variants and risk of coronary artery disease: a large angiography-based study. Clin Chim Acta. 2011 Jan 30;412(3-4):327-31
59. Zhao YX, Yin HQ, Yu QT, Qiao Y, Dai HY, Zhang MX, Zhang L, Liu YF, Wang LC, Liu de S, Deng BP, Zhang YH, Pan CM, Song HD, Qu X, Jiang H, Liu CX, Lu XT, Liu B, Gao F, Dong B. ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum Gene Ther. 2010 Nov;21(11):1545-54.
60. Feng M, Cai XJ, Zhang W, Liu XL, Chen L, Zhang Y, Zhang MX*, Zhang M*. Interleukin enhances matrix metalloproteinase-14 expression via the RAF-mitogen-activated protein kinase kinase-extracellular signal regulated kinase 1/2-activator protein-1 pathway. Clin Exp Pharmacol Physiol. 2010 Feb;37(2):162-6.
61. Cai XJ, Feng M, Chen L, Li L, Rong YY, Hu XB, Wang R, Zhang MX, Zhang Y, Zhang M. Expression and role of adiponectin receptor 1 in lipopolysaccharide induced proliferation of cultured rat adventitial fibroblasts. Cell Biol Int. 2010；14; 34 (2):163-9.
62. Cai XJ, Chen L, Li L, Feng M, Li X, Zhang K, Rong YY, Hu XB, Zhang MX, Zhang Y, Zhang M. Adiponectin Inhibits Lipopolysaccharide-Induced Adventitial Fibroblast Migration and Transition to Myofibroblasts via AdipoR1-AMPK-iNOS Pathway. Mol Endocrinol. 2010 ; 24 (1): 218-28
63. Zhang MX#*, Zhang C, Shen YH, Wang J, Li XN, Chen L, Zhang Y, Coselli JS, Wang XL. Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell. 2008 Sep;19(9):3997-4005. Epub 2008 Jul 9.
64. Zhang MX#*, Zhang C, Shen YH, Wang J, Li XN, Zhang Y, Coselli J, WangXL. Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem. 2008 May 23;283(21):14685-93.
65. Wang Y#, Zhang MX#, Meng X, Liu FQ, Yu GS, Zhang C, Sun T, Wang XP, Li L, Wang YY, Ding SF, Yang JM, Zhang Y. Atorvastatin Suppresses LPS-induced Rapid Upregulation of Toll-like Receptor 4 and its Signaling Pathway in Endothelial Cells. Am J Physiol Heart Circ Physiol. 2001; Feb 11.
